Abstract:Objective A low 1-hour glucose challenge test (GCT) result (<10th percentile for population) has been associated with neonatal morbidity, including small-for-gestational-age birth weight, and it is hypothesized that underlying maternal hypoglycemia may contribute to this neonatal morbidity. We sought to assess whether eligible patients would undergo continuous glucose monitoring to allow comparison of maternal hypoglycemia between those with a low GCT result versus controls. Study Design This exploratory study enrolled patients who completed a GCT between 24 and 30 weeks' gestation from June to September 2022. English- or Spanish-speaking participants aged ≥18 years wore a blinded continuous glucose monitor (CGM) for 10 days. There were 10 participants each in the low GCT (<82 mg/dL) and normal GCT group. Proportions were calculated to determine recruitment rates and describe the low versus normal glycemic groups across clinical and sociodemographic characteristics. Maternal hypoglycemia, defined using various proposed thresholds, was analyzed as continuous data (time duration) with Student's t -tests and categorical data (number of episodes) with chi-square tests and bivariate analyses were performed comparing participants with a low versus normal GCT. Primary outcome measures were recruitment, enrollment, and adherence rates, and overall glycemic values for each group. Results Of 64 eligible patients, 58 (91%) were approached, and of them, 20 (35%) were enrolled. All 20 participants had CGM data to review with 100% adherence. Average glucose values were similar between participants in the low GCT and normal GCT groups (111.7 ± 18.0 vs. 111.6 ± 11.7 mg/dL, p = 0.99), and participants with a low GCT value did not demonstrate more hypoglycemia than those with a normal GCT value across five proposed thresholds on CGM analysis. Conclusion In this pilot study, participants wore blinded CGMs to collect glycemic data, and those with a low GCT result did not experience more hypoglycemia than those with a normal GCT on CGM analysis. Key Points Study participants wore continuous glucose monitors in blinded mode to gather glycemic data with 100% adherence. Participants with a low GCT result (<82 mg/dL) as compared with those with a normal GCT result were not more likely to demonstrate maternal hypoglycemia using several thresholds on CGM analysis. In our cohort, there were few participants in either glycemic group who reported food insecurity or lived in a food desert. Dexcom Inc. provided 6th generation continuous glucose monitors at subsidized cost but had no input in the design of the study, data analysis or interpretation, or manuscript writing. Received: 22 April 2024 Accepted: 20 September 2024 Article published online: 16 October 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Continuous glucose monitoring for detection of glycemic variability, hypoglycemia, and hyperglycemia in women with eating disorders

Real-time Continuous Glucose Monitoring Versus Conventional Glucose Monitoring in Critically Ill Patients: a Systematic Review Study Protocol.

Verification of glycemic profiles using continuous glucose monitoring: cases with steroid use, liver cirrhosis, enteral nutrition, or late dumping syndrome

Using Continuous Glucose Monitoring to Passively Classify Naturalistic Binge Eating and Vomiting Among Adults With Binge‐Spectrum Eating Disorders: A Preliminary Investigation

Establishment Of Normal Reference Ranges For Glycemic Variability In Chinese Subjects Using Continuous Glucose Monitoring

A Pilot Study Using Continuous Glucose Monitoring among Patients with a Low 1-Hour Glucose Challenge Test Result versus Controls to Detect Maternal Hypoglycemia

Application of Continuous Glucose Monitoring System in the Assessment of Within-Day and Day-to-day Blood Glucose Excursions in Type 2 Diabetic Patients

Clinical Application of Continuous Glucose Monitoring

[Evaluating the Feature of Hypoglycemia Detected by Continuous Glucose Monitoring System During Temporary Continuous Subcutaneous Insulin Infusion in Type 2 Diabetes Patients].

Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

Assessing the temporal within-day glycemic variability during hospitalization in patients with type 2 diabetes patients using continuous glucose monitoring: a retrospective observational study

Investigating the Relationship between Morning Glycemic Variability and Patient Characteristics Using Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes

Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy

Effect of intermittently scanned continuous glucose monitoring in people with diabetes with a psychosocial indication for initiation

Glycemic Variation in Uncontrolled Graves’ Disease Patients with Normal Glucose Metabolism: Assessment by Continuous Glucose Monitoring

[Accuracy and Safety of Continuous Glucose Monitoring System in Diabetic and Non-Diabetic Subjects].

High Frequency of Severe Hyperglycemia Observed During Intensive Hematologic Care: A Prospective Study Using Continuous Glucose Monitoring

Continuous Glucose Monitoring in Subjects with Impaired Glucose Tolerance

Continuous glucose monitoring and intrapersonal variability in fasting glucose

Personal and Social-Built Environmental Factors of Glucose Variability Among Multiethnic Groups of Adults With Type 2 Diabetes: Research Protocol Using Ecological Momentary Assessment, Continuous Glucose Monitoring, and Actigraphy

Subcutaneous Continuous Glucose Monitoring in Critically Ill Patients During Insulin Therapy: a Meta-Analysis.